At 48 units on your 5mg/ml syringe, you are drawing nearly half a milliliter
Non-alcoholic fatty liver disease (NAFLD) now affects approximately 25% of adults worldwide, making it one of the most common liver conditions
Kiara DeWitt, our founder and a BSN, RN, CPN with a background in neurosurgery and pediatric nursing at Cook Childrens Hospital, built InjectCo around a simple belief: that patients deserve a clinical environment where they feel heard and where treatment decisions are made on evidence, not revenue targets
Practical recommendations include starting with the manufacturer's guidance, taking probiotics with a light meal or snack containing some fat (such as yoghurt, milk, or a small amount of nut butter), and monitoring individual tolerance